The 10 top performers
| # | Fund | 30 days | Net assets | Cost | Yield | 1 mo | YTD | 1 yr | 3 yr | 5 yr |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BBC Virtus LifeSci Biotech Clinical Trials ETF | $46.4M | 0.65% | 1.53% | -0.5% | +11.6% | +45.6% | +33.1% | -1.4% | |
| 2 | LFSC F/M Emerald Life Sciences Innovation ETF | $126.3M | 0.54% | — | +6.6% | +22.6% | +43.4% | — | — | |
| 3 | BBH VanEck Biotech ETF | $395.6M | 0.35% | 0.38% | +7.3% | +33.9% | +40.2% | +19.2% | +6.3% | |
| 4 | XBI SPDR S&P Biotech ETF | $10.73B | 0.35% | 0.36% | +0.9% | +25.0% | +39.9% | +29.9% | +3.1% | |
| 5 | BBP Virtus LifeSci Biotech Products ETF | $98.5M | 0.34% | 0% | +1.3% | +28.0% | +37.9% | +28.0% | +14.4% | |
| 6 | IBBQ Invesco Nasdaq Biotechnology ETF | $96.4M | 0.19% | 1.09% | +5.7% | +27.3% | +36.7% | +24.2% | — | |
| 7 | FBT First Trust NYSE Arca Biotechnology Index Fund | $2.81B | 0.55% | 0% | +0.5% | +28.9% | +36.5% | +24.3% | +10.6% | |
| 8 | CANC Tema Oncology ETF | $176.1M | 0.75% | 0.05% | +3.4% | +20.5% | +35.3% | +23.5% | — | |
| 9 | IBB iShares Biotechnology ETF | $9.09B | 0.44% | 0.15% | +5.2% | +26.7% | +35.1% | +21.7% | +6.6% | |
| 10 | PBE Invesco Biotechnology & Genome ETF | $281.9M | 0.59% | 1.34% | +4.6% | +21.9% | +31.8% | +22.1% | +6.4% |
Funds with less than $25 million in net assets and the 4 leveraged or inverse funds are left out of the ranking. Returns are total returns with distributions reinvested (3 and 5 years annualized), as of Nov 6, 2026.
How the top 5 compare
Growth of each fund’s value from the start of the range, distributions reinvested. The dashed gray line is the S&P 500 (SPY).
All 18 Biotechnology ETFs
Largest first. Click a heading to sort.
| Fund | Issuer | Net assets | Cost | Yield | YTD | 1 yr | 5 yr |
|---|---|---|---|---|---|---|---|
| XBI SPDR S&P Biotech ETF | SPDR (State Street) | $10.73B | 0.35% | 0.36% | +25.0% | +39.9% | +3.1% |
| IBB iShares Biotechnology ETF | iShares | $9.09B | 0.44% | 0.15% | +26.7% | +35.1% | +6.6% |
| FBT First Trust NYSE Arca Biotechnology Index Fund | First Trust | $2.81B | 0.55% | 0% | +28.9% | +36.5% | +10.6% |
| LABU Direxion Daily S&P Biotech Bull 3x Shares Leveraged | Direxion | $494.4M | 0.96% | 0.41% | +40.4% | +89.3% | -28.5% |
| BBH VanEck Biotech ETF | VanEck | $395.6M | 0.35% | 0.38% | +33.9% | +40.2% | +6.3% |
| PBE Invesco Biotechnology & Genome ETF | Invesco | $281.9M | 0.59% | 1.34% | +21.9% | +31.8% | +6.4% |
| CANC Tema Oncology ETF | Tema Global Ltd. | $176.1M | 0.75% | 0.05% | +20.5% | +35.3% | — |
| SBIO ALPS Medical Breakthroughs ETF | ALPS | $161.8M | 0.5% | 0% | +8.9% | +26.0% | +3.6% |
| LFSC F/M Emerald Life Sciences Innovation ETF | 1251 Capital Group Inc. | $126.3M | 0.54% | — | +22.6% | +43.4% | — |
| BIB ProShares Ultra Nasdaq Biotechnology Leveraged | ProShares | $101.4M | 0.95% | 0.19% | +47.7% | +68.0% | +6.1% |
| BBP Virtus LifeSci Biotech Products ETF | Virtus Investment Partners | $98.5M | 0.34% | 0% | +28.0% | +37.9% | +14.4% |
| IBBQ Invesco Nasdaq Biotechnology ETF | Invesco | $96.4M | 0.19% | 1.09% | +27.3% | +36.7% | — |
| LABD Direxion Daily S&P Biotech Bear 3x Shares Inverse | Direxion | $54.2M | 1.07% | 6.49% | -64.8% | -75.6% | -46.9% |
| FMED Fidelity Disruptive Medicine ETF | Fidelity | $51.5M | 0.5% | 0% | +17.0% | +21.9% | — |
| BBC Virtus LifeSci Biotech Clinical Trials ETF | Virtus Investment Partners | $46.4M | 0.65% | 1.53% | +11.6% | +45.6% | -1.4% |
| CNCR Range Cancer Therapeutics ETF | Exchange Traded Concepts | $8.9M | 0.79% | 0% | 0.0% | 0.0% | -20.0% |
| WDNA WisdomTree BioRevolution Fund | WisdomTree | $2.7M | 0.45% | 3.33% | +36.8% | +49.4% | -1.1% |
| BIS ProShares UltraShort Nasdaq Biotechnology Inverse | ProShares | $1.9M | 0.95% | 4.26% | -42.9% | -50.6% | -21.2% |